期刊文献+

极低出生体质量儿并支气管肺发育不良的危险因素 被引量:5

Risk Factors of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants
下载PDF
导出
摘要 目的探讨极低出生体质量儿(VLBWI)并支气管肺发育不良(BPD)的危险因素及预防对策。方法回顾性分析应用呼吸机治疗且住院28d以上的VLBWI共56例。分析20余种高危因素与BPD发生的关系。结果BPD发生率为41.07%(23/56例),占使用机械通气VLBWI的17.04%(23/135例),占所有VLBWI的6.20%(23/371例)。BPD组FiO2、吸气峰压(PIP)、呼气末正压(PEEP)、平均呼吸道压(MAP)、上机日龄、产前应用地塞米松促肺成熟、生后应用肺表面活性物质(PS)等与对照组比较差异均无显著性意义(Pa>0.05),而胎龄≤30周、出生体质量≤1250g、上机次数>2次、并肺炎、肺出血、上机5d、痰培养阳性2次以上与对照组比较均有显著性差异(Pa<0.05);多因素Logistic回归分析显示,并肺炎、使用机械通气天数回归系数为0.952、0.144;OR值分别为2.591、1.154。结论缩短应用机械通气时间、防止及减少肺部感染,尤其是严重感染是预防VLBWI发生BPD的重要措施。 Objective To investigate the risk factors, prevention and treatment of bronchopulmonary dysplasia(BPD) in very low birth weight infants(VLBWI). Methods A retrospective study was performed in VLBWI with mechanical ventilation and hospitalized more than 28 days. More than 20 factors were analyzed as the risk factors of BPD. Results The overall incidence of BPD in VLBWI with mechanical ventilation and hospitalized more than 28 days was 41.07% (23/56) ,and 17.04% (23/135)in those VLBWI who received mechanical ventilation, and 6.20% ( 23/371 ) in those infants whose birth weight ≤ 1 500 g. FiO2, peak inspiratory pressure ( PIP), positive end - expiratory pressure (PEEP), mean airway pressure( MAP), the days of starting mechanical ventilation, maternal prenatal administration of dexamethasone and usage of pulmonary surfactant to newborn had no significant differences between BPD and control groups ( Pα 〉 0.05 ). But there were significant differences in gestational age less than or equal to 30 weeks, birth weight less than 1 250 g, times of mechanical ventilation treatment ( 32 times ), pulmonary infection, pneumorrhagia, prolonged mechanical ventilation ( ≥ 5 days) and positive culture of the lower respiration secretion more than 2 times ( Pα 〈 0.05 ) ; Multivariate logistic analysis revealed that pulmonary infection with regression coefficient 0. 952, odd ratio (OR)2. 591 ;the days prolonged mechanical ventilation with regression coefficient 0. 144 ,OR 1. 154. Conclusion Shortening the duration of mechanical ventilation to prevent pneumonia, particularly serious pnenumonia, is important in preventing BPD.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第2期109-110,118,共3页 Journal of Applied Clinical Pediatrics
关键词 婴儿 极低出生体质量 支气管肺发育不良 危险因素 infant, very low birth weight bronchopulmonary dysplasia risk factors
  • 相关文献

参考文献19

二级参考文献88

  • 1金汉珍.实用新生儿学,第2版[M].北京:人民卫生出版社,1996.157-160.
  • 2Farrell PA, Fiascone JM. Bronchopulmonary dysplasia in the 1990s: A review for the pediatrician. Curr Probl Pediatr, 1997, 27 : 133 - 163.
  • 3Northway WH, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline membrane disease. N Engl J Med, 1967, 276 : 357- 368.
  • 4Ohki Y, Nako Y, Koizumi T, et al. The effects of aerosolized furosemide in infants with chronic lung disease.Acta Paediatr, 1997, 86(6) : 656- 660.
  • 5American Academy of Pediatrics Committee on Fetus and Newborn. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics, 2002, 109 : 330- 338.
  • 6Shinwell ES. The great steroid dilemma:an update. Biol Neonate, 2002, 82(4) : 288- 289.
  • 7Avent ML, Gal P, Ransom JL, et al. The role of inhaled steroids in the treatment of bronchopulmonary dysplasia. Neonatal Network, 1994, 13(3) : 63- 69.
  • 8Cole CH, Colton T, Shah BL, et al. Early inhaled glucocorticoid therapy to prevent BPD. N Eng J Med, 1999,340 : 1005- 1010.
  • 9Northway WH, Rosan, Poort. Pulmonary disease following respirator therapy of membrane hyaline-disease [J]. Neu Englj Med,1996, 276: 357-368.
  • 10Abman SH, Groothius JR. Pathophysiology and treatment of bronchopulmonary dysplasia, Current issues[J ]. Pediatr Clin North An,1994, 31:277-315.

共引文献125

同被引文献53

  • 1姚岭松,肖志辉.支气管肺发育不良的研究现状[J].中国新生儿科杂志,2007,22(1):57-59. 被引量:11
  • 2常立文.新生儿支气管肺发育不良诊治进展[J].临床儿科杂志,2007,25(3):161-165. 被引量:46
  • 3Vaucher YE. Bronchopulmonary dysplasia : An enduring challenge [J]. Pediatr Rev,2002,23 (10) :349 - 357.
  • 4Taeusch HM,Ballard RA. Avery's diseases of the newborn[M]. 7^th ed. Philadelphia : W. B.Saunders Company, 1999:634.
  • 5沈晓明,朱建幸,孙锟.尼尔森儿科学[M].17版.北京:北京大学医学出版社,2007:1734-1735.
  • 6Ballard HO, Anstead MI, Shook LA. Azithromycin in the extremely low birth weight infant for the prevention of Bronchopulmonary Dysplasia : A pilot study[ J ]. Respir Res,2007,8( 1 ) :41.
  • 7Capoluongo E,Ameglio F,Lulli P,et al. Epithelial lining fluid free IGF - I - to - PAPP - A ratio is associated with bronchopulmonary dysplasia in preterm infants[ J ]. Am J Physiol Endocrinol Metab, 2007,292 ( 1 ) : E308 - E313.
  • 8Aly H. Is there a strategy for preventing bronchopulmonary dysplasia? Absence of evidence is not evidence of absence [ J ]. Pediatrics, 2007, 119(4) :818 -820.
  • 9Geary C, Caskey M, Fonseca R, et al. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: A historical cohort study[J].Pediatrics,2008,121(1):89-96.
  • 10Steven H, Abman PM, Mourani M,et al. Bronchopulmonary dysplasia, a genetic disease [ J ]. Pediatrics, 2008,122 ( 3 ) : 658 - 659.

引证文献5

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部